Significant Ownership of TAKEDA PHARMACEUTICAL CO LTD

Signature - Title: /s/ Paul Sundberg - Paul Sundberg / Authorized Signatory
Location: Tokyo, Japan
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by TAKEDA PHARMACEUTICAL CO LTD.

Notify me when TAKEDA PHARMACEUTICAL CO LTD files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of TAKEDA PHARMACEUTICAL CO LTD

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
OVID	Ovid Therapeutics Inc.	Common Stock, par value $0.001 per share	12%	$13,172,994		8,781,996		Takeda Pharmaceutical Company Limited	08 Dec 2025
HLVX	HILLEVAX, INC.	Common Stock, par value $0.0001 per share	0%	$0		0		Takeda Pharmaceutical Company Limited	17 Sep 2025

Schedules 13D/G Reported by TAKEDA PHARMACEUTICAL CO LTD:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.